Delivering potentially transformational medicines through R&D innovation in Oncology

TB: uniting scientists to tackle one of the world’s biggest killers

The lung microbiome and the future management of respiratory disease

Your lungs are full of micro-organisms. Some are welcome guests and some are uninvited gate-crashers

Revealing the beautiful complexity of the immune system

David Roth works in immunology research and development. Here he talks to us about the complexity of the body’s defence system and how we’re working to unlock its hidden secrets to help bring new medicines to patients.

GSK’s SAM technology could revolutionise vaccines

Jeff Ulmer explains how synthetic Self-Amplifying mRNA (SAM) and ground-breaking partnerships may help us fight more conditions faster and more efficiently than ever before.

Our focus on developing the next generation of antibiotics

Developing new antibiotics is very difficult, both scientifically and financially. But our antibacterial research is focused on developing the next generation of antibiotics and we have an active pipeline of potential new medicines in development.

Delivering potentially transformational medicines through R&D innovation in Oncology

How do you test medicines in the real world?

The vaccines of tomorrow

Join our leading scientists as they go behind the science of vaccine technology.

Inclusive design: making our differences invisible

Great design is almost invisible, it’s something that is seamless and frictionless. But for anyone who has experienced poor design, the frustration and hardship are all too evident.

Unravelling the mysteries of the human genome with functional genomics

What is functional genomics technology and how can we use it to improve our chances of finding the right targets for potential medicines?

Why collaboration is essential to achieving new breakthroughs in vaccines

Emmanuel Hanon, Senior Vice President R&D at GSK Vaccines shares how one idea combined with the right type of collaboration could change the future of vaccine development.

Tackling tomorrow’s health challenges today

From eucalyptus toothpaste to a brew for the flu: tailoring products to different tastes

STEM – inspiring tomorrow’s science and engineering superstars

Meet this year’s GSK UK Young Scientist and Engineers of the Year.

Severe asthma: when nature’s natural defences work against us

Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.

COPD is more than a lung disease

Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing.

Using the immune system to fight cancer

A recent paper by GSK scientists revealed a potential new class of immunotherapy drugs to treat some cancers.

From bench to bedside: lessons in converting science into impact

How a chance encounter led to a world-first toothpaste

Inside the Open Lab

How does the Tres Cantos Open Lab offer top international scientists and academics the opportunity to pursue their own projects as part of an integrated team?

You, me and 23andMe: discovering new medicines through genetics

Explore how our new collaboration with 23andMe could help unlock the medicines of tomorrow.

How do consumer insights fuel our innovation?

By asking our consumers what matters to them, we can keep innovating and evolving our products.

How genomics is driving a new era of drug discovery

We’re in a new era of drug discovery because of a fundamental change in our understanding of human biology.

How are we redefining research in HIV?

Following the journey of a respiratory medicine

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

COPD for John just means doing everything at a slower pace

Meet John - at 80 years old, he refuses to let COPD get in the way of living the life he wants to.

Making the Ellipta® inhaler a reality

The story behind the device now used by millions of people globally

Overcoming the challenges of COPD to fulfil a lifelong dream

Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.

The science of shopping

I control my asthma, it doesn’t control me

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

When you call us, who’s the voice at the end of the line? Paul tells his story from scientist to sympathetic ear.

You'll outgrow some childhood habits, but vaccination is for life

Infectious diseases remain just as serious throughout adulthood and vaccines remain the most effective protection we have against them.

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Does lupus really know no boundaries?

There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.

Giving a bit back – Christine’s experience of clinical research

30 years and counting: the fight against HIV

The digitalisation lab: bringing the digital age to manufacturing

We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.

COPD: Our relentless pursuit for better breathing

Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient.

Getting on target in autoimmune diseases

Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?

How smart is your inhaler?

As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.

Can social media help us hear patients?

Don’t forget the pharmacists

Scientists or detectives? Seeking new clues in COPD

It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.

Inhaler innovation: more than a simple piece of plastic

At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly...

The design behind the device

Andy Dundon leads our R&D Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Vaccine manufacture: it’s complicated

Beyond manufacturing in Chile and Madagascar

Living with lupus – a patient perspective

Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.

Turbocharging the effect of vaccines

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Outgrowing asthma

Why is it that some people, particularly children, grow out of their asthma? That’s a question our scientists are asking as part of our research to better understand the disease.

Targeting the immune system through open innovation

A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?

Cell and gene therapy: a new era of medicine

Neuroscience: on the brain

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

We need more women in science to create the inclusive technologies of the future